|
1
|
Misawa K, Nosaka T, Kojima T, Hirai M and
Kitamura T: Molecular cloning and characterization of a mouse
homolog of human TNFSF14, a member of the TNF superfamily.
Cytogenet Cell Genet. 89:89–91. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang JM, Deng X, Gong W and Su S:
Chemokines and their role in tumor growth and metastasis. J Immunol
Methods. 220:1–17. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mauri DN, Ebner R, Montgomery RI, Kochel
KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH,
Spear PG and Ware CF: LIGHT, a new member of the TNF superfamily,
and lymphotoxin alpha are ligands for herpesvirus entry mediator.
Immunity. 8:21–30. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tamada K, Shimozaki K, Chapoval AI, Zhu G,
Sica G, Files D, Boone T, Hsu H, Fu YX, Nagata S, Ni J and Chen L:
Modulation of T-cell-mediated immunity in tumor and
graft-versushost disease models through the LIGHT co-stimulatory
pathway. Nat Med. 6:283–289. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harrop JA, McDonnell PC, Brigham BM, Lyn
SD, Minton J, Tan KB, Dede K, Spampanato J, Silverman C, Hensley P,
Diprinzio R, Emery JG, Deen K, Eichman C, Chabot FM, Truneh A and
Young PR: Herpesvirus entry mediator ligand(HVEM-L), a novel ligand
for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29
cell growth. J Biol Chem. 273:27548–27556. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, Kwon
BS, Jiang GW, Lu J, Tan J, Ugustus M, Carter K, Rojas L, Zhu F,
Lincoln C, Endress G, Xing L, Wang S, Oh KO, Gentz R, Ruben S,
Lippman ME, Hsieh SL and Yang D: LIGHT, a novel ligand for
lymphotoxin beta receptor and TR2/HVEM induces apoptosis and
suppresses in vivo tumor formation via gene transfer. J Clin
Invest. 102:1142–1151. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang ZH, Wu LQ, Han B, Lu Y, Lu ZH, Liu
XP, Yang K, Sui AH, Bi CY and Li JP: Expression of Fas/FasL and the
apoptosis of HepG2 cells transfected with LIGHT and IFN-γ. Chin J
Curr Adv Gen Surg. 11:301–304. 2008.
|
|
8
|
Liu XP, Wang HB, Yang K, Sui AH, Shi Q and
Qu S: Inhibitory effects of adenovirus mediated tandem expression
of RhoA and RhoC shRNAs in HCT116 cells. J Exp Clin Cancer Res.
28:522009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jemal A, Ward E, Hao Y and Thun M: Trends
in the leading causes of death in the United States, 1970–2002.
JAMA. 294:1255–1259. 2005.
|
|
10
|
Kim D, Gambhira R, Karanam B, Monie A,
Hung CF, Roden R and Wu TC: Generation and characterization of a
preventive and therapeutic HPV DNA vaccine. Vaccine. 26:351–360.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Santin AD, Bellone S, Palmieri M, Zanolini
A, Ravaggi A, Siegel ER, Roman JJ, Pecorelli S and Cannon MJ: Human
papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination
of stage IB or IIA cervical cancer patients: a phase I
escalating-dose trial. J Virol. 82:1968–1979. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tamada K and Chen L: Renewed interest in
cancer immunotherapy with the tumor necrosis factor superfamily
molecules. Cancer Immunol Immunother. 55:355–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tamada K, Shimozaki K, Chapoval AI, Zhai
Y, Su J, Chen SF, Hsieh SL, Nagata S, Ni J and Chen L: LIGHT, a
TNF-like molecule, costimulates T cell proliferation and is
required for dendritic cell-mediated allogeneic T cell response. J
Immunol. 164:4105–4110. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu KY, Kwon B, Ni J, Zhai Y, Ebner R and
Kwon BS: A newly identified member of tumor necrosis factor
receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J
Biol Chem. 274:13733–13736. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zou GM and Hu WY: LIGHT regulates CD86
expression on dendritic cells through NF-κB, but not JNK/AP-1
signal transduction pathway. J Cell Physiol. 205:437–443. 2005.
|
|
16
|
Rooney IA, Butrovich KD, Glass AA,
Borboroglu S, Benedict CA, Whitbeck JC, Cohen GH, Eisenberg RJ and
Ware CF: The lymphotoxin-beta receptor is necessary and sufficient
for LIGHT-mediated apoptosis of tumor cells. J Biol Chem.
275:14307–14315. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen MC, Hsu TL, Luh TY and Hsieh SL:
Overexpression of bcl-2 enhances LIGHT and
interferon-gamma-mediated apoptosis in Hep3BT2 cells. J Biol Chem.
275:38794–38801. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu p, Lee Y, Liu W, Chin RK, Wang J, Wang
Y, Schietinger A, Philip M, Schreober H and Fu YX: Priming of naive
T cells inside tumors leads to eradication of established tumors.
Nat Immunol. 5:141–149. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tiscornia G, Singer O and Verma IM:
Production and purification of lentiviral vectors. Nat Protoc.
1:241–245. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wiznerowicz M and Trono D: Harnessing HIV
for therapy, basic research and biotechnology. Trends Biotechnol.
23:42–47. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lever AM, Strappe PM and Zhao J:
Lentiviral vectors. J Biomed Sci. 11:439–449. 2004. View Article : Google Scholar
|
|
22
|
Buchschacher GL Jr and Wong-Staal F:
Development of lentiviral vectors for gene therapy for human
diseases. Blood. 95:2499–2504. 2000.PubMed/NCBI
|
